0001104659-21-002795.txt : 20210111
0001104659-21-002795.hdr.sgml : 20210111
20210111093041
ACCESSION NUMBER: 0001104659-21-002795
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210107
FILED AS OF DATE: 20210111
DATE AS OF CHANGE: 20210111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Renstrup Jens
CENTRAL INDEX KEY: 0001786967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 21519573
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC.
STREET 2: 100 WASHINGTON BLVD.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm2022926-12_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-07
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001786967
Renstrup Jens
C/O SPRINGWORKS THERAPEUTICS, INC.,
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief Medical Officer
Common Stock
2021-01-07
4
A
0
6075
0
A
250499
D
Stock Option (Right to Buy)
70.68
2021-01-07
4
A
0
48600
0
A
2031-01-07
Common Stock
48600
48600
D
Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on January 7, 2022, another thirty three percent (33%) to vest on January 7, 2023 and the remaining thirty four percent (34%) to vest on January 7, 2024, such that the restricted stock awards are fully vested on January 7, 2024.
svThis option shall vest in 48 equal monthly installments subject to continued service to the Company by the Reporting Person.
/s/ Francis I. Perier, Jr as Attorney-in-Fact
2021-01-11